Short Name,Full Name,Faculty,Category,Instructors,TAs,Assessment title,Assessment type,Format,weight,due date,Specific objectives,Course Outcomes: all,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Design Presentation to Clients – Interim (IP teams),Assignment,N/A,5,2016-10-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Design Portfolio ,Assignment,N/A,15,2016-09-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Journal,Assignment,N/A,15,2016-09-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Analytical essay,Assignment,N/A,15,2016-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Pharmacy Presentation ,Assignment,N/A,5,2016-12-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Pharmacy Continuing Professional Development Program Draft (collaborative with pharmacy team members),Assignment,N/A,30,2016-11-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Cheryl Sadowski,,Design Presentation - Final ,Assignment,N/A,15,2016-11-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Team Debate (Group) – Peer evaluation,Other,N/A,5,2017-03-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Final Exam,Exam,Written and multiple choice,50,2017-04-18,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Midterm Exam,Exam,Written and multiple choice,30,2017-02-27,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Team Debate (Group) – Instructor evaluation,Exam,Multiple choice,10,2017-03-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Peer Assessment,Other,N/A,5,2017-03-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ","Cox, Cheryl",,Seminar #1 Self-Assessment ,Other,N/A,0,2016-11-08,,Develop an understanding of the role and expectations of experiential learning in the curriculum ,Explore the understanding of professionalism as the ability to identify and negotiate the expectations of others,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges",Demonstrate initiative in service and learning ,Demonstrate critical thinking and reflection to optimize learning from experience and care for clients,Develop the ability to build collaborative relationships with clients and staff,Practice in an ethical manner to assure primary accountability to the client ,Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ","Cox, Cheryl",,Seminar #2 Self-Assessment,Other,N/A,0,2016-12-08,,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges",Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,Explore how the critical thinking/reflective practice of person-centred care in Pharm 300 relates to the reflective practice of client centered care in pharmacy,Demonstrate critical thinking and reflection to optimize learning from experience and care for clients,Develop the ability to build collaborative relationships with clients and staff,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Practice in an ethical manner to assure primary accountability to the client ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ","Cox, Cheryl",,Self-Assessment,Other,N/A,0,2017-03-24,,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges",Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ","Cox, Cheryl",,Seminar #3 Assignment,Assignment,N/A,0,2017-02-17,,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ","Cox, Cheryl",,Presentation ,Other,N/A,0,2017-03-01,,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ","Cox, Cheryl",,Seminar #2 Person-Centred Care  and Collaboration ,Assignment,N/A,0,2016-12-08,,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,Explore how the critical thinking/reflective practice of person-centred care in Pharm 300 relates to the reflective practice of client centered care in pharmacy,Develop the ability to build collaborative relationships with clients and staff,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Explore the meanings of citizenship and community engagement within one’s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Midterm,Exam,Written and multiple choice,35,2016-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Final,Exam,Multiple choice,50,2016-03-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Anatomy/Physiology Assignments,Assignment,N/A,15,2016-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Weekly Quizzes,Quiz,Multiple choice,10,2016-10-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Patient Case Scenario Assignment,Assignment,N/A,40,2016-10-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Therapeutic Decision-Making Assignment,Assignment,N/A,15,2016-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Participation (Coordinator and Facilitator),Participation,N/A,10,2016-12-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Final,Exam,Multiple choice,25,2016-12-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,In-Class Quiz,Quiz,Multiple choice,5,2016-02-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Midterm,Exam,Written and multiple choice,40,2016-02-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,FInal,Exam,Multiple choice,40,2016-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Group Assignment,Assignment,N/A,15,2016-03-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Class Participation,Participation,N/A,5,2017-01-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Midterm,Exam,Written and multiple choice,40,2017-02-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Final,Exam,Written and multiple choice,55,2017-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Midterm,Exam,Written and multiple choice,35,2017-02-08,,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Final,Exam,Written and multiple choice,45,2017-04-24,,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,BP Clinic and EJournal (most complete both),Assignment,N/A,5,2017-02-02,,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Seminars,Participation,N/A,15,2017-01-18,,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 4,Lab,N/A,5,2017-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Midterm,Exam,Written and multiple choice,25,2017-02-13,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Final,Exam,Multiple choice,45,2017-03-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Self-Reflection (Community Pharmacy Visit),Assignment,N/A,10,2017-01-14,,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 2,Lab,N/A,5,2017-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 3,Lab,N/A,5,2017-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 1,Lab,N/A,5,2017-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 3 Quiz,Quiz,Multiple choice,5,2017-04-05,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 1 Quiz,Quiz,Multiple choice,5,2017-03-22,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Midterm,Exam,Multiple choice,40,2017-03-20,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,
PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Final,Exam,Multiple choice,50,2017-04-24,,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Midterm,Exam,Written and multiple choice,40,2017-01-24,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain the interaction of food and drug.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Final,Exam,Written and multiple choice,60,2017-02-17,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain the interaction of food and drug.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Participation (Coordinator and Facilitator),Participation,N/A,10,2017-01-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Weekly Quizzes,Quiz,Multiple choice,10,2017-03-06,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Therapeutic Decision-Making Assignment,Assignment,N/A,15,2017-02-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Patient Case Scenario Assignment,Assignment,N/A,40,2017-03-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Final Exam,Exam,Multiple choice,25,2017-04-18,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Examination 2 (Pediatrics),Exam,Written and multiple choice,37,2017-02-08,," Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants, including premature babies, and neonates","Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).",Discuss presentation and treatment for common pulmonary pediatric illnesses; croup and bronchiolitis.,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act","Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)","Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Discuss basic neonatal care and challenges including premature birth.,Explain how pharmacokinetic parameters are different in infants and children versus adults.,Identify and discuss appropriate management plans for common pediatric concerns such as teething and fevers.,Describe the challenges of providing care in a population with limited evidence.,"Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.","Describe risks for adverse drug events in pediatric and geriatric patients, and explain why they are more susceptible to adverse events.",Identify and describe age-appropriate communication strategies.,"Describe the role that culture, religion, and ethnicity may play in health and decision-making.",Identify controversial health issues involving pediatric and geriatric populations,Discuss the management and implications involved with a diagnosis of autism.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.","Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Examination 1 (Geriatrics),Exam,Written and multiple choice,37,2017-01-23,,Categorize the types of abuse commonly suffered by seniors.,Describe the role of the pharmacist in reducing elder abuse,Describe the challenges of providing care in a population with limited evidence.,"Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.",Identify controversial health issues involving pediatric and geriatric populations,"Define and be able to use the following terms in a clinical context: geriatrics, gerontology, elderly, aging, frailty.",Describe common stereotypes and biases toward aging in our western society.," Explain the demographics of aging, and how that may impact society and the healthcare system.",Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient.,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.", List the most common chronic diseases and causes of death in seniors.,Contrast disease presentation between the young adult and the elderly adult.,Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Define polypharmacy and underutilization in terms of medications in seniors.,Contrast the presentation of adverse events in the elderly compared to the young adult.,Describe the impact of falls on the senior population.,Identify risk factors for falls in older individuals.,Describe appropriate interventions for falls.,Contrast how a geriatric syndrome is different than a disease state.,List the common geriatric syndromes.,Discuss the role of the pharmacist in medication management of seniors.,Identify methods of appropriately communicating with older adults who are hard of hearing.,Describe the role of the pharmacist in working with home care.,Identify appropriate home care supports for a given patient.,Use tools to assess medication appropriateness and medication management in seniors.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,Identify and be able to recommend aids to assist in medication management and administration.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.","Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment – Part III: Response,Assignment,N/A,10,2017-02-20,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment – Part I: Position Outline and Bibliography,Assignment,N/A,5,2017-01-26,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment – Part II: Debate,Assignment,N/A,10,2017-01-26,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Final,Exam,Multiple choice,45,2017-04-19,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice)",Lab,N/A,5,2017-01-12,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),Lab,N/A,5,2017-01-12,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #4,Quiz,Multiple choice,2,2017-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #1,Quiz,Multiple choice,2,2017-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #2,Quiz,Multiple choice,2,2017-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #3,Quiz,Multiple choice,2,2017-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #5,Quiz,Multiple choice,2,2017-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Midterm,Exam,Multiple choice,25,2017-03-30,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,
PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,OTC Submission,Assignment,N/A,10,2017-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar Löbenberg/Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,30,2017-01-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar Löbenberg/Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,40,2017-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar Löbenberg/Afsaneh Lavasanifar,,Lab assignments average of 7 lab marks,Assignment,N/A,20,2017-01-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar Löbenberg/Afsaneh Lavasanifar,,Lab Exam,Exam,Multiple choice,10,2017-03-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,2017-02-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,2017-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Final,Exam,Multiple choice,50,2017-04-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Midterm,Exam,Multiple choice,40,2016-03-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,EBCP Literacy Assignment,Assignment,N/A,20,2016-02-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar #2 Critical Appraisal,Assignment,N/A,5,2016-02-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Final,Exam,Written and multiple choice,50,2016-11-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Group EBM Project,Exam,Multiple choice,25,2016-02-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm,Exam,Written and multiple choice,40,2017-02-14,,Identify the main anatomical components of the endocrine system.,"Describe the physiological effects of pituitary, hypothalamic, adrenal, thyroid, parathyroid and pancreatic hormones.",Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment, and management of endocrine disorders; including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders., Identify the role and the responsibility of the pharmacist within the management of endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the adverse effects of drugs used to manage endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.," Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Final,Exam,Written and multiple choice,45,2017-04-19,,Identify the main anatomical components of the endocrine system.,"Describe the physiological effects of pituitary, hypothalamic, adrenal, thyroid, parathyroid and pancreatic hormones.",Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment, and management of endocrine disorders; including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders., Identify the role and the responsibility of the pharmacist within the management of endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the adverse effects of drugs used to manage endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.," Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Pre-Seminar Quiz 1,Quiz,Written and multiple choice,7,2017-02-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Pre-Seminar Quiz 2,Exam,Written and multiple choice,0,2017-02-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,EBCP Literacy Assignment,Assignment,N/A,5,2017-06-02,,Demonstrate the EBCP process for answering clinical questions in practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Journal Club ,Research,N/A,20,2017-06-20,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patient’s medication therapy.",Demonstrate skills in self–directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Individual Critical Appraisal Assignments,Assignment,N/A,10,2017-01-30,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Final Exam,Exam,Written and multiple choice,40,2017-07-11,,Demonstrate the EBCP process for answering clinical questions in practice.,Apply verbal and written communication skills important for collaboration in professional team environments.,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patient’s medication therapy.",Demonstrate skills in self–directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Group Critical Appraisal Assignments,Assignment,N/A,25,2017-01-30,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patient’s medication therapy.",Demonstrate skills in self–directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Individual readiness assessment test (iRAT) (individual),Assignment,N/A,25,2017-01-30,,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Team readiness assessment test (tRAT) (group),Assignment,N/A,10,2017-01-30,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,TDM Assignment (individual),Assignment,N/A,1,2017-01-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Submission of Appropriate Key Learning Issues on Google Forms (individual),Assignment,N/A,10,2017-01-30,,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Tutorial Evaluation ,Assignment,N/A,10,2017-01-30,,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Care Plans (group),Exam,Multiple choice,10,2017-07-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Final Exam,Exam,Multiple choice,20,2017-08-10,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Collaboration & Professional Learning Reflections (individual),Assignment,N/A,12,2017-06-25,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Documentation Notes (group) ,Assignment,N/A,10,2017-07-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Participation,Participation,N/A,5,2017-01-31,,Demonstrate professional attitude and behavior consistently and work collaboratively with other group members.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Symptom Assessment Assignment,Assignment,N/A,15,2017-06-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Case assessment documentation (5% each x 6),Assignment,N/A,30,2017-06-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Patient Assessment Lab Quizzes (5% each x 3),Quiz,Multiple choice,15,2017-06-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Final Exam,Exam,Written and multiple choice,35,2017-07-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Quiz #1,Quiz,Multiple choice,10,2017-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Quiz #2,Quiz,Multiple choice,10,2017-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Quiz #3,Quiz,Multiple choice,10,2017-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Final,Exam,Written and multiple choice,70,2017-12-11,,Perform conversions of measurement,"Compute mathematical problems using the following principles; a: density and specific gravity, b: specific volume, c: alligations d: concentrations and dilutions e: isotonic and electrolyte solutions  f: proportions ",Formulate calculations patient specific parameters and data,Demonstrate proficiency in using the Aliquot method,"Calculate concentrations of mixtures (weight/weight, weight/volume, volume/weight and volume/volume) and dilutions of stock solutions","Calculate  concentration and flow rates, infusion times and total volume of IV medications",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Midterm,Exam,Multiple choice,40,2017-10-20,,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Describe the long term health consequences of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)",Synthesize information gained from various literature resources to solve problems or make recommendations,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Final,Exam,Written and multiple choice,50,2016-11-01,,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Describe the long term health consequences of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)",Synthesize information gained from various literature resources to solve problems or make recommendations,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,
PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Rare Neurologic Disorders Assignment,Assignment,N/A,10,2017-06-29,,Summarize the impact on and care for patients with rare neurologic disorders.,Synthesize information gained from various literature resources to solve problems or make recommendations,Utilize self-directed learning abilities.,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"For each of the conditions described the student should: review the presenting signs and symptoms of the conditions of primary focus, and describe criteria used to make the diagnosis and to be able to relate the severity of the disease; discuss the therapeutic options with peers, including risks and benefits, and medication and alternative therapy choices; recommend appropriate monitoring parameters; recommend appropriate changes to therapy based on patient outcomes and monitoring parameters","Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Accept responsibility for keeping abreast of emerging technologies and drugs.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation for advocacy required for individuals with neurologic disorders.,Appreciate the roles of members of the healthcare team in caring for patients with neurologic conditions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Midterm,Exam,Written and multiple choice,40,2017-10-19,,"Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders.","Assess fluid balance based on medical history as well as presenting signs and symptoms, and recommend appropriate management of the patient.",Calculate creatinine clearance and adjust doses for medications that are renally eliminated.,"Identify the presenting signs and symptoms of electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS and describe criteria used to make the diagnosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus. ",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #2,Quiz,Multiple choice,3,2017-11-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #3,Quiz,Multiple choice,3,2017-11-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #1,Quiz,Multiple choice,3,2017-10-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Final,Exam,Written and multiple choice,50,2017-12-18,,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,Work effectively within the healthcare team.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Midterm Exam ,Exam,Multiple choice,40,2016-09-15,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.,"To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation – toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,In Class Quiz #2,Quiz,Multiple choice,10,2016-09-22,,"To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk – benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Final Exam ,Exam,Multiple choice,50,2016-10-05,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",To illustrate the rationale for the use of radioactive drugs and contrast agents for diagnosis by discussing: the various agents presently available from commercial suppliers; the physiological basis of their utility and clinical applications; their formulation and manufacture; methods of quality control and dispensing and inventory control. The use of radioactive drugs for therapy will be examined.,"This course will provide a basis for further training (either formally or on-the-job) which will provide the expertise for safe and effective handling, preparation and dispensing of radiopharmaceuticals and maintaining proper quality control and inventory.",To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.,"To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation – toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.,"To illustrate ""radiopharmaceutical kits"", and radionuclide generators for daily preparation of short-lived radiopharmaceuticals in a hospital.","To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk – benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.","Following this course, students should be able to interpret the labels on radiopharmaceuticals; perform simple calculations related to radioactive decay.","This course will provide pharmacists with fundamental knowledge of contemporary clinical imaging modalities, including the use of radiopharmaceuticals and contrast agents in clinical diagnosis and therapy. Such a basic understanding will enable pharmacists, as members of a Health Team, to communicate knowledgeably with physicians, nurses, technicians and patients regarding the use of various imaging techniques. Emphasis will be placed on radiopharmaceuticals and contrast agents used with these procedures. The use of radioactive materials for in vitro and in vivo tests, and for radiation therapy, will be addressed. An understanding of the general principles underlying the biologic effects of various levels of radiation will assist the pharmacist in allaying patients' fears and misapprehensions regarding radioactivity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,In Class Quiz #1,Quiz,Multiple choice,10,2016-09-07,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk – benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. Velázquez,,Final Exam,Exam,Written and multiple choice,50,2017-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. Velázquez,,Midterm Exam,Exam,Written and multiple choice,50,2017-10-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Final Exam,Exam,Written,23,2017-12-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TDM Assessment ,Assignment,N/A,5,2017-08-24,,Demonstrate an understanding of key concepts in pharmacokinetics and therapeutic drug monitoring and apply pharmacokinetic principles to resolve drug therapy problems and optimize pharmacotherapy outcomes.,"Apply acquired therapeutic knowledge to confidently and competently manage medication therapy (including monitoring and follow-up) for patients with both the common disease states covered and those beyond, even if complex interplay between disease states exists. ","Demonstrate critical thinking, therapeutic knowledge, and the use of a therapeutic thought process (patient care process) in prioritizing and resolving a patient’s drug related problems, making appropriate recommendations related to ambiguous medication-related issues and those where evidence is limited or contradictory. ","Develop and defend a detailed care plan (with supporting chart documentation) to resolve and/or prevent drug related problems, applying principles of evidence-based medicine. ","Effectively translate therapeutic knowledge to patients with complex care issues and/or those of a sensitive nature that present challenges in communication, in a variety of settings. ","Demonstrate the self-directed learning, self-reflection, and peer assessment skills required for continuous professional development and precepting students. ","Apply the communication, collaboration, and leadership skills gained through teamwork to other professional team environments.",Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients’ pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Tutorial Evaluation: TMCA and TACL,Assignment,N/A,12,2017-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Documentation Notes ,Assignment,N/A,15,2017-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Key Learning Issues and Care Plans  ,Assignment,N/A,2,2017-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Exam 1: Midterm,Exam,Written,19,2017-10-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Exam 2: Midterm ,Exam,Written,23,2017-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Midterm,Exam,Multiple choice,34,2017-10-23,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,"Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Final,Exam,Multiple choice,44,2017-12-20,,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture Participation,Participation,N/A,2,2016-12-14,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Pharmacokinetic web-based problem assignments (15 in total),Assignment,N/A,20,2017-08-29,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Midterm Exam,Exam,Multiple choice,50,2017-09-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Final Exam,Exam,Written and multiple choice,50,2017-10-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Finding and Evaluating Information on the Web,Assignment,N/A,0,2017-09-25,,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Identify the functions and services offered by the health sciences library.,Use library resources and library facilities effectively to access relevant drug information. ,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3 – Drug Information Queries 1,Assignment,N/A,50,2017-10-23,,Use library resources and library facilities effectively to access relevant drug information. ,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Demonstrate a systematic step-wise approach to answer drug information requests.,Determine the depth of response required for any given question. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Follow-up on drug information requests where appropriate.,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Electronic Resources Assignment,Assignment,N/A,0,2017-10-03,,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Identify the functions and services offered by the health sciences library.,Use library resources and library facilities effectively to access relevant drug information. ,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3 – Drug Information Queries 2,Assignment,N/A,50,2017-10-24,,Use library resources and library facilities effectively to access relevant drug information. ,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Demonstrate a systematic step-wise approach to answer drug information requests.,Determine the depth of response required for any given question. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Follow-up on drug information requests where appropriate.,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Reflective Paper - Evaluation of Group Experience (40%),Essay,N/A,40,2017-12-10,,"Describe elements of group development, group dynamics, and group effectiveness.",Apply principles of program evaluation to plan and evaluate a group experience.,Present information and views effectively in written and oral presentation formats.,Apply critical thinking skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Group Assignment - Learning Theories (40%),Group,N/A,40,2017-10-28,,"Discuss and contrast theories of learning including: behavioral, cognitive, humanist, social cognitive, constructivist, critical.","Develop education plans using principles of needs assessment, planning, development, and evaluation for diverse audiences including professionals, public, patients and groups of patients.",Present information and views effectively in written and oral presentation formats.,Facilitate professional learning.,Demonstrate collaboration in learning.,Demonstrate self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Contribution to Discussions - Sessions 4-6,Participation,N/A,10,2017-08-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Contribution to Discussions - Sessions 1-3,Participation,N/A,10,2017-08-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Final Exam,Exam,Written,25,2017-07-28,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Patient Case Scenario Assignment,Assignment,N/A,40,2017-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Therapeutic Decision-Making Assignment,Exam,Other,15,2017-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Weekly Quizzes ,Exam,Multiple choice,10,2017-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Participation (Coordinator and Facilitator),Participation,N/A,10,2017-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Midterm ,Exam,Written,30,2017-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Participation/Professionalism ,Participation,N/A,10,2017-08-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Symptom Assessment Assignment ,Assignment,N/A,10,2017-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Physical Assessment Quizes,Quiz,Multiple choice,10,2017-08-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Final Exam,Exam,Written and multiple choice,40,2017-12-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Performance Review Midpoint and Final ,Other,N/A,0,2016-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,20 hours Deadline,Other,N/A,0,2016-12-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,25 Hour Deadline,Other,N/A,0,2016-12-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Assignment Presentations,Performance,N/A,0,2017-03-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Final Performance Review ,Other,N/A,0,2017-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Small Group Meetings,Other,N/A,0,2017-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Overview Reflection Assignment ,Assignment,N/A,0,2017-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Midterm,Exam,Multiple choice,35,2016-09-28,,Define the types of toxins which create problems in the environment.,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury.",Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms.,Understand basic processes governing pharmacokinetic behaviour of drugs.,". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations.","Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues",Describe the types and organization of muscles.,Describe nerve conduction and neuromuscular and synaptic transmission.,Explain how the various sensory mechanisms function.,Describe action potential,Describe membrane transport.,Explain resting potential.,"Describe lysosomal function, membrane function and membrane transport.","Physiology: Describe body composition, body fluids, and fluid compartments.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Final,Exam,Multiple choice,65,2016-10-25,,"Anatomy: Describe cell structure, cell function and tissue types","Physiology: Describe body composition, body fluids, and fluid compartments.","Describe lysosomal function, membrane function and membrane transport.",Explain resting potential.,Describe membrane transport.,Describe action potential,Explain how the various sensory mechanisms function.,Describe nerve conduction and neuromuscular and synaptic transmission.,Describe the types and organization of muscles.,"Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues",". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations.",Understand basic processes governing pharmacokinetic behaviour of drugs.,Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms.,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury.","List seven basic classes of disease based on disease mechanisms, and give examples.",Discuss the molecular and cellular events underlying the different classes of disease.,Correlate drug therapy with disease mechanisms for representative major diseases.,"Understand and use medical terminology related to disease, to a degree sufficient to understand the pathophysiology content in the subsequent blocks","Toxicology: Understand basic toxicological concepts, and the different areas of toxicology.",Define the types of toxins which create problems in the environment.,Explain the mechanism of toxicity of individual toxins which cause problems in the environment,Describe hazard identification and assessment methods,Determine dose-response assessment,Determine exposure assessment,Examine applicable Canadian and American legislation governing environmental discharge. Understand where forensic toxicology is used ,Understand toxicity and safety assessment of natural health products,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Weekly Tasks/ Appraisals,Assignment,N/A,10,2017-06-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,EBCP Literacy Assignment,Assignment,N/A,5,2017-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,"""Tools for Practice"" Evidence Summary ",Assignment,N/A,25,2017-11-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Final Exam,Exam,Written and multiple choice,30,2017-12-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Midterm Exam,Exam,Written and multiple choice,30,2017-10-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Hot Topic Assignment,Assignment,N/A,2,2016-10-16,,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab reports,Assignment,N/A,12,2016-12-07,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacist’s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,48,2016-11-04,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacist’s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,
PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,38,2016-09-28,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacist’s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Midterm,Exam,Written and multiple choice,35,2017-10-13,,Demonstrate an awareness of the evolving practice environment of pharmacy.,Demonstrate an understanding of the concept of professionalism ,Understand the pharmacy regulatory bodies in Canada ,"Identify basic concepts, principles, and components of health care delivery and the health care system in Canada and the province of Alberta. ",Understand the role of Complementary and Alternative Medicine providers in the health care system and how pharmacists can collaborate with them to optimize patient care and safety.,Discuss the payment model within the realm of pharmacy ,Demonstrate an understanding of the concepts and principles of Health and Health Promotion.,Describe the role of health behaviour theory in pharmacy practice. ,"Describe, compare and contrast the impact of the social determinants of health",Describe the historical development of pharmacy through trends that have led to the current practice philosophy.,Integrate knowledge from various sources/activities with respect to pharmacy practice.,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Final,Exam,Written and multiple choice,40,2017-12-15,,Summarize the patient care process and how it relates to the pharmacist’s role in the health care system. ,Understand the interprofessional learning pathway and roles of students in other health professions ,Describe the role of theory in health care,Apply introductory knowledge of the health care system for solving problems in practice.,Apply the patient care process to solve problems,Demonstrate appropriate writing skills at post-secondary level.,Apply theories of patient behaviours to identify methods of intervention for treatment outcomes.,Analyse your own personal health beliefs and how they impact your clinical decision making process.,Integrate knowledge from various sources/activities with respect to pharmacy practice.,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Pharmacy Organizations Quiz,Quiz,Multiple choice,10,2017-09-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Interprofessional (IP) Launch Self Reflection,Assignment,N/A,15,2017-10-05,,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Quizzes (Lecture and Pre-case Readings),Quiz,Multiple choice,5,2017-06-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Midterm Examination (Case Topics 1-3),Exam,Written and multiple choice,30,2017-10-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Pharmacokinetic/TDM Assignment,Assignment,N/A,10,2017-11-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Tutorial Evaluation ,Performance,N/A,15,2017-06-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Final Examination,Exam,Written and multiple choice,40,2017-12-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab Reflection,Assignment,N/A,10,2017-01-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab Final,Exam,Other,35,2017-03-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,, Learning Opportunities (In-Class),Participation,N/A,10,2017-01-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Written Final,Exam,Written and multiple choice,35,2017-03-17,,Identify communication challenges associated with providing care to a patient whose first language is not English. ,Outline effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Define shared decision making and differentiate it from other decision making models.,Identify several strategies for effectively communicating risk,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Explain a process to manage emotional consults,Identify core principles and key skills of motivational interviewing,"Compare and contrast concordance, compliance, and adherence frameworks ",Differentiate strategies to communicate with patients with vision and hearing loss. ,Compare and contrast intentional and unintentional medication taking behaviours ,Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Describe the elements of a medication history,Apply communication techniques for monitoring medications ,Explain the importance of stress management in professional life,Reflect on communication skills,Establish organization and flow while taking a full medication history,"Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.", Practice self-care activities to manage stress in professional life, Detect and address barriers to patients medication taking behaviors using supportive probing techniques ," Provide timely, clear responses that are tailored to the context and audience.","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ","Communicate effectively with people with vision, hearing loss or who are using a translator",Apply the Three Talk model to make a shared decisions,Select and integrate communication techniques to effectively communicate risk to patients,"Engage in respectful, empathetic, compassionate, non-judgmental, culturally safe, tactful conversations with patients and health team members.",Engage in effective partnerships with their patients to support positive behaviour changes,Accept responsibility for communicating professionally through both student and professional career ,Advocate for pharmacists role in monitoring medication therapy at the medication refill,Foster curiosity to understand and appreciate patients unique life experience,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Contributions to eClass/Participation ,Participation,N/A,20,2017-08-21,,Discuss the role of feedback  related to preceptorship of pharmacy students.,Examine the application of learning styles in the education of professionals. ,Apply theoretical frameworks for collaboration and  groups. ,"Explore current issues on collaboration: teamwork, leadership, communication. ",Present information and views effectively in written and oral presentation formats.,Apply reflective and critical thinking skills. ,Facilitate student and professional learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Reflective Paper ,Assignment,N/A,20,2017-10-03,,Relate core beliefs about teaching and learning to educational experiences.,Discuss the role of feedback  related to preceptorship of pharmacy students.,Examine the application of learning styles in the education of professionals. ,Present information and views effectively in written and oral presentation formats.,Demonstrate appreciation for self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Final Paper,Assignment,N/A,40,2017-12-05,,Apply theoretical frameworks for collaboration and  groups. ,"Explore current issues on collaboration: teamwork, leadership, communication. ",Present information and views effectively in written and oral presentation formats.,Apply reflective and critical thinking skills. ,Demonstrate respect for diversity of views and experiences. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Education Plan ,Assignment,N/A,20,2017-10-31,,"Design, deliver, and evaluate education plans using theoretical frameworks ",Examine the application of learning styles in the education of professionals. ,"Explore current issues on collaboration: teamwork, leadership, communication. ",Present information and views effectively in written and oral presentation formats.,Facilitate student and professional learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Midterm,Exam,Multiple choice,40,2017-11-22,,Describe the specific laboratory tests and other diagnostic tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the conditions of primary focus.",Discuss the complementary and alternative medicine used in GI diseases.,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Antidiarrheals ii. Laxatives iii. Antinauseants iv. Antiemetics v. Antacids vi. Anti-gas vii. Antispasmodics viii. Drugs Stimulating Gastrointestinal Motility (Prokinetic Agents) ix. Proton-Pump Inhibitors x. H2 receptor antagonists xi. Mucosal protective agents Sucralfate, Prostaglandin analogs (ie misoprostil), Colloidal Bismuth Compounds xii. Antibiotics used for PUD xiii. Aminosalicylates xiv. Corticosteroids used in IBD xv. Immunosuppressants used in IBD (including azathioprine, 6-mercaptopurine, cyclosporine, methotrexate) xvi. Tumour necrosis factor – alpha antagonists (infliximab, adalimumab, certolizumab, golimumab) xvii. Pharmacotherapy for complications of cirrhosis (ie diuretics, spironolactone, beta-blockers, octreotide, lactulose, and metronidazole)",Describe the societal and economic impact of the conditions of primary focus.,Identify ethical issues surrounding treatment of the conditions of primary focus,Discuss drugs that can be toxic to the liver,"Describe the treatment options for oral health such as canker sores, dry mouth, and mouth care.",Discuss the types of ostomy supplies used by patients with ostomies,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the conditions of primary focus, including use of specific target drugs for condition as well as complementary and alternative therapies",Discuss monitoring parameters for each of the disease of focus,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Final,Exam,Written and multiple choice,50,2017-12-15,,Explain the anatomy of the gastrointestinal tract; describe the functions of the gastrointestinal tract.  ,Explain the anatomy of the liver; describe the functions of the liver . ,Identify applicable health system resources.,Appreciate the interdisciplinary approach to management of the condition,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Discuss monitoring parameters for each of the disease of focus,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2 Quiz,Quiz,Written,5,2017-06-23,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1 Quiz,Quiz,Written,5,2017-06-23,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Written Final,Exam,Multiple choice,30,2017-11-07,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient's’ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Offer and receive constructive feedback,Demonstrate professional communication,Critically reflect on communication in patient care,Tailor communication to specific contexts and audiences,Write data section of a clinical documentation note after a standardized patient encounter,Introduce self and identify patient,Use small talk to establish rapport,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Gather sufficient information to evaluate medication appropriateness,"Identify and name patient feelings (i.e., empathetic responding) ",Demonstrate effective non-verbal communication skills,Establish flow and organization in a patient encounter,Display confidence in a patient encounter,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,In-Class Learning Opportunities,Quiz,Multiple choice,5,2017-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab grades,Participation,N/A,0,2017-09-01,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient's’ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Offer and receive constructive feedback,Demonstrate professional communication,Critically reflect on communication in patient care,Tailor communication to specific contexts and audiences,Write data section of a clinical documentation note after a standardized patient encounter,Introduce self and identify patient,Use small talk to establish rapport,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Gather sufficient information to evaluate medication appropriateness,"Identify and name patient feelings (i.e., empathetic responding) ",Demonstrate effective non-verbal communication skills,Establish flow and organization in a patient encounter,Display confidence in a patient encounter,Appreciate the patient’s experience and perspective in health care ,Accept responsibility for communicating professionally through both student and professional career ,Value reflection and its role in lifelong learning,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Reflection,Assignment,N/A,15,2017-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab Final,Performance,N/A,50,2017-11-01,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient's’ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Offer and receive constructive feedback,Demonstrate professional communication,Critically reflect on communication in patient care,Tailor communication to specific contexts and audiences,Write data section of a clinical documentation note after a standardized patient encounter,Introduce self and identify patient,Use small talk to establish rapport,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Gather sufficient information to evaluate medication appropriateness,"Identify and name patient feelings (i.e., empathetic responding) ",Demonstrate effective non-verbal communication skills,Establish flow and organization in a patient encounter,Display confidence in a patient encounter,,,,,,,,,,,,,,
PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Pharmacy Speechcraft by Toastmasters,Participation,N/A,0,2017-09-01,,Demonstrate effective public speaking and presentation skills,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Midterm Exam,Exam,Other,25,2017-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Final Exam,Exam,Other,35,2018-04-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Professionalism,Participation,N/A,5,2017-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Semester 2,Assignment,N/A,10,2017-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Integrated Cases (2),Assignment,N/A,15,2017-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Semester 1,Assignment,N/A,10,2017-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,7 Specified online exercises,Other,N/A,8,2017-08-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Midterm,Exam,Written and multiple choice,25,2017-09-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,7 Quizzes ,Quiz,Multiple choice,19,2017-08-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Assignment #2: Case reflection and learning application,Assignment,N/A,2,2017-09-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Final,Exam,Written and multiple choice,45,2017-10-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Assignment #1: Case Submission and question,Assignment,N/A,1,2017-09-05,,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,"Semester 2 Labs 5,6,7,8,9,10",Assignment,N/A,12,2017-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,FINAL,Exam,Other,35,2018-04-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Professionalism ,Participation,N/A,5,2017-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Integrated Cases,Assignment,N/A,15,2017-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,"Semester 1: Labs 1,2,3,4",Assignment,N/A,8,2017-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,MIDTERM,Exam,Other,25,2017-12-21,,Describe the principles of shared decision making (SDM) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Seminar Assessments/Activities,Quiz,Multiple choice,15,2017-10-23,,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,Identify ethical issues in the management of mental health conditions.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm Exam,Exam,Written and multiple choice,40,2017-11-27,,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,Identify ethical issues in the management of mental health conditions.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Final Exam,Exam,Written and multiple choice,45,2017-12-13,,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,Identify ethical issues in the management of mental health conditions.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Final ,Exam,Written and multiple choice,65,2017-12-13,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of blood supply and the lymphatic system of the human.,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products",Identify ethical issues surrounding treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring",Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems,Critically evaluate the appropriateness and reliability of information from literature resources,Utilize self-directed learning abilities,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Midterm,Exam,Multiple choice,30,2017-11-02,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of blood supply and the lymphatic system of the human.,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products",Identify ethical issues surrounding treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring",Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems,Critically evaluate the appropriateness and reliability of information from literature resources,Utilize self-directed learning abilities,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar Quiz,Quiz,Multiple choice,5,2017-12-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Peer Performance Evaluation (Final),Participation,N/A,2,2017-12-04,,"Apply best practices in staff selection, training, development and evaluation.",Help maintain a healthy work environment and assist with conflict management.,Develop a willingness to accept leadership roles where appropriate.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Midterm,Exam,Written and multiple choice,25,2017-10-16,,"Clarify roles, responsibilities and expertise of team members, identifying overlaps and gaps.",Apply regulatory and profession best practices to manage the distribution of medications in a variety of practice settings.,"Evaluate factors critical to safe and efficient medication distribution systems including pharmacy layout, workflow, technology and automation.","Apply best practices in staff selection, training, development and evaluation.",Critique the impact of funding and payment policies on the provision of professional services.,Describe strategic planning principles.,Describe marketing principles in the context of supply and demand for professional services.,Utilize inventory control concepts to maintain an inventory control system.,Help maintain a healthy work environment and assist with conflict management.,"Contribute to planning, organizing and performing of work to be done, and integrating evidence while evaluating the results.","Set priorities and manage their time to balance patient care, workflow and practice requirements.",Adapt their practice to fulfill evolving professional roles.,"Anticipate, recognize and manage human, environmental and medication distribution situations that place patients at risk.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #3,Quiz,Written and multiple choice,1,2017-09-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #4,Quiz,Written and multiple choice,1,2017-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #5,Quiz,Written and multiple choice,1,2017-09-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #6,Quiz,Written and multiple choice,1,2017-10-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #7,Quiz,Written and multiple choice,1,2017-10-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #8,Quiz,Written and multiple choice,1,2017-11-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #1,Quiz,Written and multiple choice,1,2017-09-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #2,Quiz,Written and multiple choice,1,2017-09-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #9,Quiz,Written and multiple choice,1,2017-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #10,Quiz,Written and multiple choice,1,2017-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Presentation – Student Evaluation (Group Mark),Group,N/A,5,2017-11-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Presentation – Instructor / Guest Panel Evaluation (Group Mark),Group,N/A,10,2017-10-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Peer Performance Evaluation (Midpoint),Participation,N/A,2,2017-10-02,,"Apply best practices in staff selection, training, development and evaluation.",Help maintain a healthy work environment and assist with conflict management.,Develop a willingness to accept leadership roles where appropriate.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Written Report (Group Mark),Assignment,N/A,10,2017-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Final,Exam,Written and multiple choice,35,2017-12-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Electronic Resources Assignment,Assignment,N/A,0,2017-10-03,,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Use library resources and library facilities effectively to access relevant drug information. ,Identify the functions and services offered by the health sciences library.,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Finding and Evaluating Information on the Web,Assignment,N/A,0,2017-09-25,,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Use library resources and library facilities effectively to access relevant drug information. ,Identify the functions and services offered by the health sciences library.,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3 – Drug Information Queries 2,Assignment,N/A,50,2017-10-24,,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,Follow-up on drug information requests where appropriate.,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Determine the depth of response required for any given question. ,Demonstrate a systematic step-wise approach to answer drug information requests.,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Use library resources and library facilities effectively to access relevant drug information. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3 – Drug Information Queries 1,Assignment,N/A,50,2017-10-23,,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,Follow-up on drug information requests where appropriate.,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Determine the depth of response required for any given question. ,Demonstrate a systematic step-wise approach to answer drug information requests.,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Use library resources and library facilities effectively to access relevant drug information. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,